Novelgen
Find Us
← Back to list
China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

BioPharma DiveJonathan GardnerNovember 19, 2026
A commission called on U.S. lawmakers to act quickly to prevent an overdependence on China that could leave American patients vulnerable to supply chain weaponization.
Read original article
← Back to list